All In MedTech

Device Trial Radar · NCT02363543

Comparison of Hyalomatrix and Integra Wound Matrix on Burn Wounds

Last checked: Nov 19, 2026Latest source record: Aug 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Withdrawn

Status

Withdrawn

Enrollment

0

Actual

Start

Feb 2016

Primary completion

May 2016

Study completion Jul 2016

Sponsor

Lead sponsor
Medline IndustriesNot on our public-company list
Sponsor type
Industry
First posted
Feb 16, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this randomized, comparative study is to determine whether Hyalomatrix is as effective as IntegraTM Meshed Bilayer Wound Matrix when used in subjects who receive concurrent treatments with both products on their first and/or second degree burns located on both hands.

Conditions

  • Bandages

Interventions

  • HyalomatrixDevice

  • IntegraDevice

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Wound Infection RateTime frame: Up to 21 days
  2. Number of days required for wound healingTime frame: Up to 21 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.